Biopharma industry eyes 2025 bounceback, grapples with uncertainty over Trump return
By Deena Beasley SAN FRANCISCO (Reuters) – The biopharmaceutical industry is aiming for a 2025 reversal of last year’s slump in investor returns
By Deena Beasley SAN FRANCISCO (Reuters) – The biopharmaceutical industry is aiming for a 2025 reversal of last year’s slump in investor returns
WASHINGTON (Reuters) – The U.S. government posted an $87 billion budget deficit in December, reduced partly by a shift of benefit payments
BUENOS AIRES (Reuters) -Argentine monthly inflation ticked up slightly in December, data showed on Tuesday, though the annual rate continued to slow
PARIS (Reuters) – French Prime Minister Francois Bayrou on Tuesday told lawmakers that France was drowning in debt, but pledged to listen
By Andrew MacAskill and Catarina Demony LONDON (Reuters) -The British minister responsible for financial services and fighting corruption resigned on Tuesday after weeks
By Marc Jones LONDON (Reuters) – Hopes of a ceasefire deal to end the war in Gaza lifted the region’s government bond markets
By Corina Pons and David Latona MADRID (Reuters) – Spanish Prime Minister Pedro Sanchez’s opponents on Tuesday said a proposed tax on property
Investing.com – UK assets have been in the spotlight of late, and given this uncertainty prompted Morgan Stanley (NYSE:MS) to
By Marwa Rashad LONDON (Reuters) – Donald Trump will attend next week’s World Economic Forum meeting in Davos digitally, its organisers said on
By Laura Gottesdiener and Diego Oré MEXICO CITY (Reuters) – In late November, U.S. President-elect Donald Trump sent shockwaves through global trade by